Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 157

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 157
---
 
    $(0.08) 
    $(0.18)
  
    Diluted 
    $(0.08) 
    $(0.18)

    Weighted
    average number of common stock outstanding: 

    Basic 
     28,783,045  
     26,405,109 
  
    Diluted 
     28,783,045  
     26,405,109 

The
accompanying notes are an integral part of these financial statements

F-4

JUPITER
NEUROSCIENCES, INC.

STATEMENTS
OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

    Shares  
    Amount  
    in
    Capital  
    Deficit  
    Deficit 

    Common
    Stock  
    Additional
    Paid  
    Accumulated  
    Total Stockholders’
                                                                                Equity 

    Shares  
    Amount  
    in
    Capital  
    Deficit  
     (Deficit) 
  
    December
    31, 2023 
     26,526,405  
    $2,652  
    $17,778,498  
    $(23,582,504) 
    $(5,801,354)
  
    Stock-based
    compensation 
     -  
     -  
     1,840,908  
     -  
     1,840,908 
  
    Issuance
    of restricted stock units for forgiveness of accrued salary 
     -  
     -  
     10,000  
     -  
     10,000 
  
    Issuance
    of stock options for forgiveness of accrued salary 
     -  
     -  
     50,000  
     -  
     50,000 
  
    Restricted
    stock issued for consulting agreements 
     3,487,500  
     349  
     (349) 
     -  
     - 
  
    Sale
    of common stock 
     112,500  
     11  
     149,989  
     -  
     150,000 
  
    Stock
    issued in connection with automatic conversion of convertible notes 
     227,447  
     23  
     636